Schwabe Pharma Belgium SRL
34.1 FTESchwabe Pharma Belgium reported total assets of €3.13m at the end of the 2025 financial year (annual accounts filed with the NBB on 18 May 2026), with 34.1 full-time equivalents.
By total assets for 2025, Schwabe Pharma Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Schwabe Pharma Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +15 % Headcount (avg FTE) -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Schwabe Pharma Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 May 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 05 Aug 2022
Schwabe Pharma Belgium's financial analysis
- Solvency44.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Schwabe Pharma Belgium
Schwabe Pharma Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0427.547.195
- VAT number
- BE0427547195
- Peppol
- Registered · 0208:0427547195 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Jul 1985
- Registered office
- 2550 Kontich
- Size
- Small · 34.1 FTE
- Latest accounts
- 2025 · filed on 18 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Schwabe Pharma Belgium (SRL) has been based in Kontich since 1985, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 299,748 € and equity of €1.39m; its revenue is not published. With 34.1 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 44.6%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Schwabe Pharma Belgium
Companies in the same business, of comparable size and area, outside its group.
- F Care Systems Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €3.15m
- embecta Belgium Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €3.18m
- Laboratoires Lohmann & Rauscher Manufacture of pharmaceutical preparations Liège · balance sheet €4.03m
- Medical Services Boom Wholesale of pharmaceutical and medical goods Boom · balance sheet €1.64m
- Fresenius Medical Care Belgium Wholesale of pharmaceutical and medical goods Willebroek · balance sheet €21.9m
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- ALL-in-1 Wholesale of pharmaceutical and medical goods Schelle · balance sheet €8.97m
- Sasmar Pharmaceuticals Wholesale of pharmaceutical and medical goods Overijse · balance sheet €3.07m
Frequently asked questions about Schwabe Pharma Belgium
What is the revenue of Schwabe Pharma Belgium?
Schwabe Pharma Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Schwabe Pharma Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0427547195 for Schwabe Pharma Belgium, if the company is VAT-registered. Its company number (CBE) is 0427.547.195.
Where is the registered office of Schwabe Pharma Belgium?
According to the CBE register, the registered office of Schwabe Pharma Belgium is in 2550 Kontich.
What is the equity of Schwabe Pharma Belgium?
At the close of the 2025 financial year, the equity of Schwabe Pharma Belgium amounts to 1,394,139 €, a solvency of 44.6% of total assets.
How many people work at Schwabe Pharma Belgium?
34.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Schwabe Pharma Belgium?
The register lists 2 active mandates at Schwabe Pharma Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Schwabe Pharma Belgium within its sector?
By total assets for 2025, Schwabe Pharma Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Schwabe Pharma Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →